Pathology and diagnosis of SMARCB1-deficient tumors

Cancer Genetics

Volumn 207, Issue 9, 2014, Pages 358-364

  Margol, Ashley S ^a,b   Judkins, Alexander R ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Atypical teratoid rhabdoid tumors; Renal rhabdoid tumors; SMARCB1 SNF5 BAF47 INI1; Soft tissue rhabdoid tumors

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; NUCLEAR PROTEIN; SMOOTH MUSCLE ACTIN; SWI SNF CHROMATIN REMODELLING COMPLEX PROTEIN; UNCLASSIFIED DRUG; VIMENTIN; DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; SWI-SNF-B CHROMATIN-REMODELING COMPLEX; TRANSCRIPTION FACTOR; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

CANCER DIAGNOSIS; CANCER MORPHOLOGY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOSS; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALIGNANT RHABDOID TUMOR; MEDULLOBLASTOMA; MOSAICISM; NEUROPATHOLOGY; NONSENSE MUTATION; PHENOTYPE; PROTEIN EXPRESSION; REVIEW; RHABDOID TUMOR; SMARCB1 GENE; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; CENTRAL NERVOUS SYSTEM NEOPLASMS; GENETICS; INFANT; KIDNEY NEOPLASMS; MUTATION; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; SOFT TISSUE NEOPLASMS;

CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD, PRESCHOOL; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; MUTATION; RHABDOID TUMOR; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84920121902     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2014.07.004     Document Type: Review

References (52)

1. Hollmann T.J., Hornick J.L. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011, 35:E47-E63.
2. Rorke L.B., Packer R., Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. JNeurooncol 1995, 24:21-28.
3. Woehrer A., Slavc I., Waldhoer T., et al. Incidence of atypical teratoid/rhabdoid tumors in children a population-based study by the Austrian Brain Tumor Registry, 1996-2006. Cancer 2010, 116:5725-5732.
4. Hoff von K., Hinkes B., Dannenmann-Stern E., et al. Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 2011, 57:978-985.
5. Madigan C.E., Armenian S.H., Malogolowkin M.H., et al. Extracranial malignant rhabdoid tumors in childhood: the Childrens Hospital Los Angeles experience. Cancer 2007, 110:2061-2066.
6. Buscariollo D.L., Park H.S., Roberts K.B., et al. Survival outcomes in atypical teratoid rhabdoid tumor for patients undergoing radiotherapy in a Surveillance, Epidemiology, and End Results analysis. Cancer 2012, 118:4212-4219.
7. Weeks D.A., Beckwith J.B., Mierau G.W., et al. Rhabdoid tumor of kidney: a report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol 1989, 13:439.
8. Gardner S.L., Asgharzadeh S., Green A., et al. Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumors. Pediatr Blood Cancer 2008, 51:235-240.
9. Chi S.N., Zimmerman M.A., Yao X., et al. Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. JClin Oncol 2009, 27:385-389.
10. Tekautz T.M., Fuller C.E., Blaney S., et al. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. JClin Oncol 2005, 23:1491-1499.
11. Beckwith J.B., Palmer N.F. Histopathology and prognosis of Wilms tumors: results from the first National Wilms' Tumor Study. Cancer 1978, 41:1937-1948.
12. Haas J.E., Palmer N.F., Weinberg A.G., et al. Ultrastructure of malignant rhabdoid tumor of the kidney. Hum Pathol 1981, 12:646-657.
13. Schmidt D., Harms D., Ziegler G. Malignant rhabdoid tumor of the kidney. Histopathology, ultrastructure and comments on differential diagnosis. Virchows Arch A Pathol Anat Histopathol 1982, 398:101-108.
14. Seo I.S., Min K.W., Brodhecker C., et al. Malignant renal rhabdoid tumour. Immunohistochemical and ultrastructural studies. Histopathology 1988, 13:657-666.
15. Kodet R., Newton W.A., Sachs N., et al. Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the intergroup rhabdomyosarcoma study. Hum Pathol 1991, 22:674-684.
16. Tsuneyoshi M., Daimaru Y., Hashimoto H., et al. Malignant soft tissue neoplasms with the histologic features of renal rhabdoid tumors: an ultrastructural and immunohistochemical study. Hum Pathol 1985, 16:1235-1242.
17. Berry P.J., Vujanić G.M. Malignant rhabdoid tumour. Histopathology 1992, 20:189-193.
18. Parham D.M., Peiper S.C., Robicheaux G., et al. Malignant rhabdoid tumor of the liver. Evidence for epithelial differentiation. Arch Pathol Lab Med 1988, 112:61-64.
19. Hunt S.J., Anderson W.D. Malignant rhabdoid tumor of the liver. A distinct clinicopathologic entity. Am J Clin Pathol 1990, 94:645-648.
20. Sotelo-Avila C., Gonzalez-Crussi F., deMello D., et al. Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients. Semin Diagn Pathol 1986, 3:151-163.
21. Frierson H.F., Mills S.E., Innes D.J. Malignant rhabdoid tumor of the pelvis. Cancer 1985, 55:1963-1967.
22. Parham D.M., Weeks D.A., Beckwith J.B. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol 1994, 18:1010-1029.
23. Tsuneyoshi M., Daimaru Y., Hashimoto H., et al. The existence of rhabdoid cells in specified soft tissue sarcomas. Histopathological, ultrastructural and immunohistochemical evidence. Virchows Arch A Pathol Anat Histopathol 1987, 411:509-514.
24. Briner J., Bannwart F., Kleihues P., et al. Malignant small cell tumour of the brain with intermediate filaments-a case of primary cerebral rhabdoid tumour [Abstract]. Pediatr Pathol 1985, 3:117-118.
25. Bonnin J.M., Rubinstein L.J., Palmer N.F., et al. The association of embryonal tumors originating in the kidney and in the brain. A report of seven cases. Cancer 1984, 54:2137-2146.
26. Biggs P.J., Garen P.D., Powers J.M., et al. Malignant rhabdoid tumor of the central nervous system. Hum Pathol 1987, 18:332-337.
27. Biegel J.A., Tan L., Zhang F., et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Cancer Res 2002, 8:3461-3467.
28. Biegel J.A., Zhou J.Y., Rorke L.B., et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res 1999, 59:74-79.
29. Judkins A.R., Mauger J., Ht A., et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004, 28:644-650.
30. Hasselblatt M., Gesk S., Oyen F., et al. Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 2011, 35:933-935.
31. Haberler C., Laggner U., Slavc I., et al. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Am J Surg Pathol 2006, 30:1462-1468.
32. Perry A., Fuller C.E., Judkins A.R., et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol 2005, 18:951-958.
33. Allen J.C., Judkins A.R., Rosenblum M.K., et al. Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case study. Neuro Oncol 2006, 8:79-82.
34. Chacko G., Chacko A.G., Dunham C.P., et al. Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma. JNeurooncol 2007, 84:217-222.
35. Hasselblatt M., Oyen F., Gesk S., et al. Cribriform neuroepithelial tumor (CRINET): a nonrhabdoid ventricular tumor with INI1 loss and relatively favorable prognosis. JNeuropathol Exp Neurol 2009, 68:1249-1255.
36. Smith M.J., Walker J.A., Shen Y. Expression of SMARCB1 (INI1) mutations in familial schwannomatosis. Hum Mol Genet 2012, 21:5239-5245.
37. Park J.Y., Kim E., Kim D.W., et al. Cribriform neuroepithelial tumor in the third ventricle: a case report and literature review. Neuropath 2012, 32:570-576.
38. Smith M.J., Wallace A.J., Bowers N.L., et al. Frequency of SMARCB1 mutations in familial and sporadic schwannomatosis. Neurogenetics 2012, 13:141-145.
39. Sestini R., Bacci C., Provenzano A., et al. Evidence of a four-hit mechanism involving SMARCB1 and NF2 in schwannomatosis-associated schwannomas. Hum Mutat 2008, 29:227-231.
40. Eaton K.W., Tooke L.S., Wainwright L.M., et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 2011, 56:7-15.
41. Hulsebos T.J., Plomp A.S., Wolterman R.A., et al. Germline mutation of INI1/SMARCB1 in familial schwannomatosis. Am J Hum Genet 2007, 80:805-810.
42. Carter J.M., O'Hara C., Dundas G., et al. Epithelioid malignant peripheral nerve sheath tumor arising in a schwannoma, in a patient with "neuroblastoma-like" schwannomatosis and a novel germline SMARCB1 mutation. Am J Surg Pathol 2012, 36:154-160.
43. Judkins A.R. Immunohistochemistry of INI1 expression: a new tool for old challenges in CNS and soft tissue pathology. Adv Anat Pathol 2007, 14:335-339.
44. Hornick J.L., Cin P.D., Fletcher C. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol 2009, 33:542-550.
45. Kohashi K., Oda Y., Yamamoto H., et al. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 2008, 32:1168-1174.
46. Hoot A.C., Russo P., Judkins A.R., et al. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004, 28:1485-1491.
47. Cheng J.X., Tretiakova M., Gong C., et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol 2008, 21:647-652.
48. Russo P., Biegel J.A. SMARCB1/INI1 alterations and hepatoblastoma: another extrarenal rhabdoid tumor revealed?. Pediatr Blood Cancer 2009, 52:312-313.
49. Le Loarer F., Zhang L., Fletcher C.D., et al. Consistent SMARCB1 homozygous deletions in epithelioid sarcoma and in a subset of myoepithelial carcinomas can be reliably detected by FISH in archival material. Genes Chromosomes Cancer 2014, 53:475-486.
50. Biegel J.A. Molecular genetics of atypical teratoid/rhabdoid tumors. Neurosurg Focus 2006, 20:E11.
51. Wang X., Haswell J.R., Roberts C.W. Molecular pathways: SWI/SNF (BAF) complexes are frequently mutated in cancer-mechanisms and potential therapeutic insights. Clin Cancer Res 2014, 20:21-27.
52. Witkowski L., Carrot-Zhang J., Albrecht S., et al. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet 2014, 46:438-443.